In the news

The pros and cons of having fixed lines of cancer treatments

Read article from our CEO, Duleek Ranatunga, following this link here.

See what we have in the works

Our drug discovery pipeline is focused on a range of indications from breast to lung cancer. Explore more about our pipeline.